Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Top-Line Results From a 16-Week, Multicenter, Randomized, Double-Blind Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s500, 2024. DOI: 10.25251/skin.8.supp.500. Disponível em: https://skin.dermsquared.com/skin/article/view/3073. Acesso em: 18 apr. 2026.